{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:10:20Z","timestamp":1791429020797,"version":"4.3.3"},"reference-count":103,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000960","name":"American College of Rheumatology Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp;amp; Research"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence\u2010based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A panel of rheumatologists, orthopedic surgeons specializing in hip and knee arthroplasty, and methodologists was convened to construct the key clinical questions to be answered in the guideline. A multi\u2010step systematic literature review was then conducted, from which evidence was synthesized for continuing versus withholding antirheumatic drug therapy and for optimal glucocorticoid management in the perioperative period. A Patient Panel was convened to determine patient values and preferences, and the Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence and the strength of recommendations, using a group consensus process through a convened Voting Panel of rheumatologists and orthopedic surgeons. The strength of the recommendation reflects the degree of certainty that benefits outweigh harms of the intervention, or vice versa, considering the quality of available evidence and the variability in patient values and preferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease\u2010modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to withhold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based on low\u2010 or moderate\u2010quality evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This guideline should help decision\u2010making by clinicians and patients regarding perioperative antirheumatic medication management at the time of elective THA or TKA. These conditional recommendations reflect the paucity of high\u2010quality direct randomized controlled trial data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acr.23274","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T01:03:02Z","timestamp":1497574982000},"page":"1111-1124","source":"Crossref","is-referenced-by-count":87,"title":["2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty"],"prefix":"10.1002","volume":"69","author":[{"given":"Susan M.","family":"Goodman","sequence":"first","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Springer","sequence":"additional","affiliation":[{"name":"OrthoCarolina Hip and Knee Center Charlotte North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"McMaster University Hamilton Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Abdel","sequence":"additional","affiliation":[{"name":"Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Dasa","sequence":"additional","affiliation":[{"name":"Louisiana State University New Orleans"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0398-2308","authenticated-orcid":false,"given":"Michael","family":"George","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ora","family":"Gewurz\u2010Singer","sequence":"additional","affiliation":[{"name":"University of Michigan Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Giles","sequence":"additional","affiliation":[{"name":"Columbia University New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Johnson","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine Bronx New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Lee","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Fontana California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Mandl","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Mont","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sculco","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sporer","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Stryker","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Turgunbaev","sequence":"additional","affiliation":[{"name":"American College of Rheumatology Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Brause","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia F.","family":"Chen","sequence":"additional","affiliation":[{"name":"Rothman Institute, Thomas Jefferson University Hospital Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gililland","sequence":"additional","affiliation":[{"name":"University of Utah Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Goodman","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Hurley\u2010Rosenblatt","sequence":"additional","affiliation":[{"name":"Rockefeller University New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Kirou","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-6674","authenticated-orcid":false,"given":"Elena","family":"Losina","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb","family":"Michaud","sequence":"additional","affiliation":[{"name":"National Data Bank for Rheumatic Diseases, Wichita, Kansas and University of Nebraska Medical Center Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Mikuls","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Russell","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery\/Weill Cornell Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sah","sequence":"additional","affiliation":[{"name":"Dearborn\u2010Sah Institute for Joint Restoration Fremont California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Miller","sequence":"additional","affiliation":[{"name":"American College of Rheumatology Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolph","family":"Yates","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"234","article-title":"Improved health\u2010related quality of life with effective disease\u2010modifying antirheumatic drugs: evidence from randomized controlled trials","volume":"14","author":"Strand V","year":"2008","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.07.014"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130617"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38384"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38344"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057067"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38231"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202758"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22497"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151373"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140011"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150525"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141251"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121171"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1086\/666641"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24060"},{"key":"e_1_2_8_18_1","first-page":"573","article-title":"Management of perioperative tumour necrosis factor \u03b1 inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta\u2010analysis","volume":"55","author":"Goodman SM","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10529"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2012.02.022"},{"key":"e_1_2_8_22_1","first-page":"22","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.015248"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.06.010"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.07.010"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192690"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2404"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.9408.EBO746"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39490.551019.BE"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39493.646875.AE"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2089"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.11.017"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.03.013"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.02.003"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.3.214"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.RHU.0000062514.54375.bd"},{"key":"e_1_2_8_40_1","first-page":"CD000957","article-title":"Methotrexate for treating rheumatoid arthritis","volume":"6","author":"Lopez\u2010Olivo MA","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_41_1","first-page":"S2664","article-title":"Flares occur frequently in RA patients undergoing arthroplasty [abstract]","volume":"67","author":"Goodman SM","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0880-2"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"e_1_2_8_44_1","first-page":"CD005468","article-title":"TNF\u2010\u03b1 inhibitors for ankylosing spondylitis","volume":"4","author":"Maxwell LJ","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1014302"},{"key":"e_1_2_8_46_1","first-page":"CD007356","article-title":"Rituximab for rheumatoid arthritis","volume":"1","author":"Lopez\u2010Olivo MA","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_47_1","first-page":"CD007649","article-title":"Certolizumab pegol (CDP870) for rheumatoid arthritis in adults","volume":"9","author":"Ruiz Garcia V","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.5.656"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38779"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.06.012"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-013-0074-x"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-298"},{"key":"e_1_2_8_53_1","first-page":"CD004525","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"5","author":"Lethaby A","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2772-6"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-012-1035-7"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202470"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1200057"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.734"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq343"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1526-y"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2009.01457.x"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.4.339"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2010.25.1.1"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0754-0"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2009.02296.x"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.098822"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091025"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-9-52"},{"key":"e_1_2_8_69_1","first-page":"883","article-title":"Risks and benefits of tumor necrosis factor\u2010\u03b1 inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials","volume":"35","author":"Saad AA","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_70_1","first-page":"2398","article-title":"The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis","volume":"33","author":"Gartlehner G","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.035287"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0336-2"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-eular.3288"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-eular.2781"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.5331"},{"key":"e_1_2_8_77_1","first-page":"S997","article-title":"Serious adverse events associated with using biological agents to treat rheumatic diseases: network meta\u2010analysis from a national guideline panel [abstract]","volume":"65","author":"Tarp S","year":"2013","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_78_1","first-page":"852","article-title":"Safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta\u2010analysis","volume":"36","author":"He Y","year":"2013","journal-title":"Drug Safety"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-eular.276"},{"key":"e_1_2_8_80_1","first-page":"S93","article-title":"Meta\u2010analysis of malignancies, serious infections, and serious adverse events with tofacitinib or biologic treatment in rheumatoid arthritis clinical trials","volume":"40","author":"Ahadieh S","year":"2013","journal-title":"J Pharmacokinetics Pharmacodynamics"},{"key":"e_1_2_8_81_1","first-page":"S1854","article-title":"The safety of anti\u2010TNF biologic agents in rheumatoid arthritis: a meta\u2010analysis of 35 RCTs [abstract]","volume":"64","author":"Lin T","year":"2012","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502012000400022"},{"key":"e_1_2_8_83_1","first-page":"S878","article-title":"The risk of serious infection with and without anti\u2010TNF therapy in rheumatoid arthritis and ankylosing spondylitis: a meta\u2010analysis [abstract]","volume":"63","author":"Cormier H","year":"2011","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.734"},{"key":"e_1_2_8_85_1","first-page":"1343","article-title":"Anti\u2010TNF therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta\u2010analysis of randomized controlled trials","volume":"37","author":"Rieder S","year":"2010","journal-title":"J Rheumatol"},{"key":"e_1_2_8_86_1","doi-asserted-by":"crossref","first-page":"AB4","DOI":"10.1016\/j.jaad.2009.11.054","article-title":"Incidence of serious infectious events with methotrexate treatment: metaanalysis of randomized controlled trials","volume":"62","author":"Powers J","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_8_87_1","first-page":"749","article-title":"Rituximab for rheumatoid arthritis: a meta\u2010analysis and systematic review","volume":"2","author":"Volkmann ER","year":"2010","journal-title":"Clin Med"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2007.12.001"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.01.004"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-015-0229-0"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80164-9"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007305297"},{"key":"e_1_2_8_93_1","first-page":"417","article-title":"Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta\u2010analysis","volume":"56","author":"Tarp S","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309106174"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1387-5"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121368"},{"key":"e_1_2_8_98_1","first-page":"1697","article-title":"Meta\u2010analysis of malignancies, serious infections, and serious adverse events with tofacitinib or biologic treatment in rheumatoid arthritis clinical trials [abstract]","author":"Ahadieh S","year":"2012","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206028"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-016-3265-5"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2015.10.007"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.143.12.1222"},{"key":"e_1_2_8_103_1","first-page":"1","article-title":"Prevention of herpes zoster: recommendation of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_8_104_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874312920131210005"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.23274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.23274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:23:57Z","timestamp":1759422237000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.23274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/acr.23274"],"URL":"https:\/\/doi.org\/10.1002\/acr.23274","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]}}}